MOSCOW (MRC) -- Akzo Nobel has acquired Xylazel S.A., a 100% subsidiary of Pharma Mar S.A., as per the company's press release.
With this acquisition AkzoNobel strengthens its business and becomes a leader in the decorative paints market in Spain. It also means the company is now the leader in the country's woodcare segment and has strengthened its position in metal care. The transaction marks the 45-year anniversary of AkzoNobel on the Spanish market.
Xylazel has about 100 employees, with one production facility in Porrino. Revenue for 2017 totaled approximately EUR20 million.
Thierry Vanlancker,CEO of AkzoNobel, said: "As a part of our transformative strategy, we continue to focus on leading market positions delivering leading performance. This couples organic growth with strategic bolt-on acquisitions on top of operational excellence and continuous improvement. By acquiring Xylazel, we will be able to further grow our business in the region and strengthen our position as the leading paints and coatings company in Europe."
Ruud Joosten, COO of AkzoNobel, added: "We are proud to add the leading brands Xylazel and Oxirite to our portfolio. Xylazel has a 43-year-old heritage on the Spanish market and a leading position in DIY, professional and industrial sectors of wood protection. This will strengthen our position in Spain and will allow us to offer our customers a wider portfolio of innovative and sustainable products."
As MRC wrote before, in June 2018, AkzoNobel entered into an agreement to acquire 100% of the shares of Fabryo Corporation S.R.L. (Fabryo), becoming the leader in the Romanian decorative paints market.
Akzo Nobel N.V., trading as AkzoNobel, is a Dutch multinational, active in the fields of decorative paints, performance coatings and specialty chemicals. Headquartered in Amsterdam, the company has activities in more than 80 countries, and employs approximately 55,000 people.
MRC